Home > Healthcare > Medical Devices > Diagnostic Devices > Home Sleep Apnea Testing Devices Market

Home Sleep Apnea Testing Devices Market Analysis

  • Report ID: GMI4439
  • Published Date: Aug 2022
  • Report Format: PDF

Home Sleep Apnea Testing Devices Market Analysis

Based on test type, the market is divided into type 2, type 3, and type 4. Consumer preference for type 3 tests is rising, due to portability and ease of use. Their high sensitivity and specificity also aid in the accurate diagnosis of obstructive sleep apnea. Additionally, the introduction of novel type 3 tests with greater convenience and lower technical complexity has increased considerably. These factors will foster industry expansion from the type 3 segment, which held a 65% revenue share in 2021 and will be valued at over USD 2,240 million by 2030.
 

Global Home Sleep Apnea Testing Devices Market Share, By Region

On the regional front, North America will emerge as a lucrative revenue pocket for the home sleep apnea testing devices market and record revenue of over USD 1,100 million by 2030, which can be credited to the robust presence of key product manufacturers. Furthermore, an increase in the prevalence of sleep disorders has been observed across the region. To limit the disease burden, patients are emphasizing early-stage diagnosis through the usage of home testing devices.
 

In countries including the U.S., symptoms of sleep apnea such as trouble concentrating, chronic headaches, and interrupted sleep are observed among several people. As per 2022 data from the Sleep Foundation, nearly 17% of women and 34% of men are diagnosed with obstructive sleep apnea in the U.S. As a result, home sleep apnea monitoring devices will emerge as a significant diagnostic tool, thereby stimulating regional industry dynamics.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global market for home sleep apnea testing devices crossed USD 810 million in 2021 and is set to depict a CAGR of 16.8% through 2030.

The type 3 segment accounted for 65% of the home sleep testing devices industry share in 2021 and will be valued over USD 2,240 million by 2030, owing to its attributes such as portability, ease of use, and high sensitivity and specificity.

North America’s home sleep apnea testing devices industry will be valued at USD 1,100 million by 2030, due to the high prevalence of sleep disorders and awareness of early-stage diagnosis.

The competitive landscape of the home sleep apnea testing devices industry is inclusive of companies such as Koninklijke Philips N.V., Compumedics Limited, Itamar Medical Inc., Natus Medical Inc., SOMNOmedics GmbH, Resmed, and Nox Medical, among others.

Home Sleep Apnea Testing Devices Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 14
  • Tables & Figures: 81
  • Countries covered: 18
  • Pages: 95
 Download Free Sample